Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Rare Thyroid Therapeutics International AB

Clinical trials sponsored by Rare Thyroid Therapeutics International AB, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

Experimental drug shows promise for rare genetic syndrome in toddlers Results expected Jul 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1 Not yet finished but already full! 1 Completed 1

Experimental drug shows promise for rare genetic syndrome in toddlers

Disease control Ongoing

This phase 2 trial tests the drug tiratricol (Triac) in 22 young boys (up to 30 months old) with MCT8 deficiency, also known as Allan-Herndon-Dudley syndrome. The goal is to see if the drug can improve brain development and reduce harmful thyroid effects in the body. Participants…

Phase 2 • Sponsor: Rare Thyroid Therapeutics International AB • Aim: Disease control

Last updated Jun 27, 2026 09:06 UTC